STL Volume 4 Number 4

Update on Drugs and Drug News

Update on Drugs and Drug News: March, 1999

Update on: Methoxsalen Uvadex Becaplermin 0.01% Regranex®Aldesleukin Proleukin®Post-herpetic neuralgia Lidoderm® patch Betamethasone valerate foam Luxiq® 0.12% Paclitaxel Taxop®Dietary supplements, Temozolomide Temodal®Terbinafine HCl cream 1% Lamisil®
image of silk fabric and dry skin

Psoriasis Treatments Under Development

A review of this list of agents that are presently undergoing clinical trial. Although only a few of the drugs on this list will gain regulatory approval, what is exciting is the likelihood that some new agents will be approved and will radically alter the way we treat psoriasis.
image of silk fabric and dry skin

Focus on Diane-35®

Diane-35®, known as Dianette® in some countries, is a combination of cyproterone acetate 2 mg and ethinyl estradiol 0.035 mg. It has recently received regulatory clearance in Canada, but has not yet been approved by the US FDA.